Prevention and treatment of tuberculosis in solid organ transplant recipients

Cybele L. Abad, Raymund R. Razonable

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Introduction: Tuberculosis (TB) in solid organ transplant (SOT) recipients is associated with significant morbidity and mortality. Its management in transplant recipients is difficult and highly complex, given the underlying immunosuppression and the risks of drug–drug interactions imposed by immunosuppressive drugs that are needed to maintain the transplant allograft. Areas covered: We provide a brief review of TB in SOT and discuss the clinical indications, mechanisms of action and drug resistance, drug–drug interactions, and adverse effects of anti-TB drugs. We provide a summary of recent clinical trials, which serve as the foundation for current recommendations. We further include relevant updates on new agents being evaluated for clinical use in TB management. Expert commentary: TB causes significant morbidity in SOT recipients. The drugs used in the treatment for latent TB and active disease in SOT are similar to the regimens used in the general population. However, TB disease in transplant recipients is more difficult to manage because of the potential for hepatotoxicity and the complex drug–drug interactions with immunosuppressive drugs. We believe that alternative regimens suited for the vulnerable transplant population, and more therapeutic drug options are needed given the adverse toxicities associated with currently approved anti-TB drugs.

Original languageEnglish (US)
Pages (from-to)63-73
Number of pages11
JournalExpert Review of Anti-Infective Therapy
Issue number1
StatePublished - Jan 2 2020


  • Mycobacterium tuberculosis
  • anti-TB drugs
  • prevention
  • solid organ transplant
  • treatment

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)
  • Virology
  • Infectious Diseases


Dive into the research topics of 'Prevention and treatment of tuberculosis in solid organ transplant recipients'. Together they form a unique fingerprint.

Cite this